6.38
-0.13(-2.00%)
Currency In USD
| Previous Close | 6.51 |
| Open | 6.45 |
| Day High | 6.54 |
| Day Low | 6.26 |
| 52-Week High | 8.25 |
| 52-Week Low | 3.54 |
| Volume | 133,800 |
| Average Volume | 102,520 |
| Market Cap | 148.63M |
| PE | -17.24 |
| EPS | -0.37 |
| Moving Average 50 Days | 6.95 |
| Moving Average 200 Days | 5.67 |
| Change | -0.13 |
If you invested $1000 in Journey Medical Corporation (DERM) since IPO date, it would be worth $644.44 as of June 24, 2025 at a share price of $6.38. Whereas If you bought $1000 worth of Journey Medical Corporation (DERM) shares 3 years ago, it would be worth $2,038.34 as of June 24, 2025 at a share price of $6.38.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
GlobeNewswire Inc.
Jun 20, 2025 12:30 PM GMT
Emrosi™ (DFD-29; 40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) demonstrated efficacy independent of body weight differences when treating rosaceaSCOTTSDALE, Ariz., June 20, 2025 (GLOB
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
GlobeNewswire Inc.
Jun 09, 2025 12:30 PM GMT
National TV Segment Highlights FDA-Approved Treatment for Rosacea Segment premiered on Monday, June 9 and will be rebroadcast on Thursday, June 19, at 7:30 a.m. PT/ ET SCOTTSDALE, Ariz., June 09, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
GlobeNewswire Inc.
May 07, 2025 8:01 PM GMT
Company to host conference call to discuss financial results and provide a corporate update on May 14, 2025 at 4:30 p.m. ETSCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: